NCT03532646

Brief Summary

Endoscopic complications such as gastro-esophageal reflux disease, ulcera, gastritis, bile reflux, anastomotic stricture and so on are described after gastric bypass surgery. The incidence of these complications after RYGB versus MGB/OAGB are getting observed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

April 24, 2018

Completed
28 days until next milestone

First Posted

Study publicly available on registry

May 22, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2019

Completed
Last Updated

April 30, 2024

Status Verified

April 1, 2024

Enrollment Period

4.4 years

First QC Date

April 24, 2018

Last Update Submit

April 27, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Complication

    Pathological finding during upper endoscopy

    Up to 15 years post surgery

Secondary Outcomes (4)

  • Weight Loss since Surgery

    Up to 15 years post surgery

  • toxic status

    Up to 15 years post surgery

  • toxic status II

    Up to 15 years post surgery

  • Revisional Surgery

    Up to 15 years post surgery

Study Arms (2)

group 1: RYGB

OTHER

All patients who underwent RYGB and were readmitted to upper endoscopy are getting observed

Procedure: upper endoscopy

group 2:MGB/OAGB

OTHER

All patients who underwent MGB/OAGB and were readmitted to upper endoscopy are getting observed

Procedure: upper endoscopy

Interventions

endoscopy of the gastrointestinal tract

group 1: RYGBgroup 2:MGB/OAGB

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all patients who underwent RYGB or MGB/OAGB as a primary surgery and were readmitted to tho hospital undergoing upper endoscopy are included

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sana obesity center

Remscheid, 42859, Germany

Location

Related Publications (2)

  • De Palma GD, Forestieri P. Role of endoscopy in the bariatric surgery of patients. World J Gastroenterol. 2014 Jun 28;20(24):7777-84. doi: 10.3748/wjg.v20.i24.7777.

  • Abd Ellatif ME, Alfalah H, Asker WA, El Nakeeb AE, Magdy A, Thabet W, Ghaith MA, Abdallah E, Shahin R, Shoma A, Dawoud IE, Abbas A, Salama AF, Ali Gamal M. Place of upper endoscopy before and after bariatric surgery: A multicenter experience with 3219 patients. World J Gastrointest Endosc. 2016 May 25;8(10):409-17. doi: 10.4253/wjge.v8.i10.409.

MeSH Terms

Conditions

Obesity, Morbid

Interventions

Gastroscopy

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Christine Stier, MD

    Sana Klinikum Offenbach/Sana Klinikum Remscheid

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: All patients who underwent RYGB and MGB/OAGB readmitted for complications in our centre of excellence are getting observed
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr. med. Sonja Chiappetta, MD, senior consultant, principal investigator

Study Record Dates

First Submitted

April 24, 2018

First Posted

May 22, 2018

Study Start

October 1, 2014

Primary Completion

March 1, 2019

Study Completion

March 1, 2019

Last Updated

April 30, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Data will be published anonymous in a peer review journal

Locations